BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 18, 2000
View Archived Issues
Purpurinimide photosensitizers with in vivo tumoricidal effects
Read More
Medarex and IDM expand partnership, announce phase III trial
Read More
Melatonin aids in benzodiazepine discontinuation
Read More
Athersys and Elan form joint venture to develop therapeutic protein for AIDS
Read More
Estrogenic activities described for 7alpha-thioestratrienes
Read More
Strategic collaboration formed by 3-D and DuPont
Read More
Sonus and Abbott amend EchoGen marketing agreement
Read More
Cel-Sci updates shareholders on progress during 1999
Read More
Solvay launches three products in 1999
Read More
Promising new atherosclerosis treatment expected to enter clinical trials later this year
Read More
Topical tazarotene effective in congenital ichthyosis
Read More
International collaboration to create HIV vaccine for developing countries
Read More
Metabolex outlines company's goals at BIO CEO and Investor Conference
Read More
Alza outlines growth strategy at annual financial analysts meeting
Read More
Novartis executes option for oral salmon calcitonin
Read More
Isis Pharmaceuticals makes important progress on many fronts in 1999
Read More
European patent describes preparation and activity of new erythromycin antibiotics
Read More
New series of taxanes designed at BMS
Read More
AstraZeneca portfolio includes new series of P2T antagonists
Read More
New prostate cancer therapy to be studied in men with no other effective treatment options
Read More
UCSD researchers report fundamental breakthrough in treating, preventing shock
Read More
Agents for HCV under study at Ajinomoto
Read More
Polyhydroxyalkylpyrazine derivatives for diabetes synthesized at Aventis
Read More
Pierre Fabre designs structurally novel inhibitors of protein prenylation
Read More
Potent and selective alpha1D-adrenoceptor antagonists presented by Abbott
Read More
FDA approves first vaccine for prevention of invasive pneumococcal disease in infants and toddlers
Read More
Adenosine A1 antagonists as alternatives to diuretics in CHF
Read More